Short Interest in Halberd Co. (OTCMKTS:HALB) Expands By 208.2%

Halberd Co. (OTCMKTS:HALB – Get Free Report) was the target of a significant increase in short interest in June. As of June 15th, there was short interest totaling 409,891 shares, an increase of 208.2% from the May 31st total of 133,008 shares. Based on an average daily volume of 1,861,083 shares, the short-interest ratio is presently 0.2 days.

Halberd Price Performance

Shares of Halberd stock remained flat at $0.00 during trading hours on Monday. The stock had a trading volume of 50,500 shares, compared to its average volume of 769,361. Halberd has a 12 month low of $0.00 and a 12 month high of $0.00.

Get Halberd alerts:

About Halberd

(Get Free Report)

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Read More

• Five stocks we like better than Halberd
• onsemi: What the Market Gets Wrong, You Can Get Right
• Is McCormick a Steal Ahead of Game-Changing Unilever Deal?
• Qualcomm’s Investor Day Just Changed the Growth Story Forever
• JPMorgan Stands by Sky-High Broadcom Target as Shares Slide

Receive News & Ratings for Halberd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halberd and related companies with MarketBeat.com's FREE daily email newsletter.